Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444924 · ClinicalTrials.gov registry record · Phase 2
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
A Phase 2 study of Post Operative Pain and Gynecologic Cancer, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT01444924 is a Phase 2 study of Post Operative Pain and Gynecologic Cancer that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 75 participants, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01444924, a Phase 2 study of Post Operative Pain and Gynecologic Cancer, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Bupivicaine
Study Locations (1)
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01444924
The ClinicalTrials.gov registry entry for NCT01444924 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (68% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01444924 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01444924 about?
NCT01444924 is a clinical study titled "Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery". This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.
What is the current status of trial NCT01444924?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2011-09. Estimated completion is 2013-03.
What conditions does trial NCT01444924 study?
This clinical trial studies the following conditions: Post Operative Pain, Gynecologic Cancer.
What interventions are being tested in trial NCT01444924?
The interventions under investigation include: Placebo (DRUG), Bupivicaine (DRUG).
Who is sponsoring clinical trial NCT01444924?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01444924 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement
COMPLETED · Phase 2
-
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
COMPLETED · Phase 2
-
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy
COMPLETED · Phase 2
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Sensory Outcomes in Active Substance Users
RECRUITING
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.